Gregory J. Opiteck

2.6k total citations
42 papers, 1.9k citations indexed

About

Gregory J. Opiteck is a scholar working on Molecular Biology, Spectroscopy and Immunology. According to data from OpenAlex, Gregory J. Opiteck has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Spectroscopy and 6 papers in Immunology. Recurrent topics in Gregory J. Opiteck's work include Mass Spectrometry Techniques and Applications (11 papers), Advanced Proteomics Techniques and Applications (10 papers) and Analytical Chemistry and Chromatography (8 papers). Gregory J. Opiteck is often cited by papers focused on Mass Spectrometry Techniques and Applications (11 papers), Advanced Proteomics Techniques and Applications (10 papers) and Analytical Chemistry and Chromatography (8 papers). Gregory J. Opiteck collaborates with scholars based in United States, Germany and United Kingdom. Gregory J. Opiteck's co-authors include James W. Jorgenson, Robert J. Anderegg, Stanley A. Hefta, Ashok Dongre, Kenneth C. Lewis, M. Arthur Moseley, Ji Gao, Mark S. Friedrichs, Nicole Ginanni and Douglas M. Sheeley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Gregory J. Opiteck

41 papers receiving 1.8k citations

Peers

Gregory J. Opiteck

SPECT

PHYSI

C. Gonnet France

Juncong Yang Canada

Claire André France

Natalia Govorukhina Netherlands

David Wang‐Iverson United States

Jean W. Lee United States

David L. Springer United States

Alessia Lodi United States

Mark G. Qian United States

Patrick Bennett United States

C. Gonnet France

Gregory J. Opiteck

526 ×0.5

SPECT

442 ×0.4

245 ×0.7

288 ×1.4

75 ×0.6

PHYSI

Citations per year, relative to Gregory J. Opiteck Gregory J. Opiteck (= 1×) peers C. Gonnet

Countries citing papers authored by Gregory J. Opiteck

Since Specialization

Citations

This map shows the geographic impact of Gregory J. Opiteck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Opiteck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Opiteck more than expected).

Fields of papers citing papers by Gregory J. Opiteck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Opiteck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Opiteck. The network helps show where Gregory J. Opiteck may publish in the future.

Co-authorship network of co-authors of Gregory J. Opiteck

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Opiteck. A scholar is included among the top collaborators of Gregory J. Opiteck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Opiteck. Gregory J. Opiteck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sewastianik, Tomasz, et al.. (2025). Regional distribution of HLA frequencies in the USA: implications for TCR-based therapies. Journal for ImmunoTherapy of Cancer. 13(5). e011441–e011441. 1 indexed citations

Asano, Koichiro, Nicola A. Hanania, Ian Pavord, et al.. (2020). Effect of the DP2 antagonist, GB001, on asthma worsening in patients with mild-moderate asthma. Journal of Allergy and Clinical Immunology. 145(2). AB20–AB20. 1 indexed citations

Dellon, Evan S., Margaret H. Collins, Yehudith Assouline-Dayan, et al.. (2019). Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study. Journal of Allergy and Clinical Immunology. 143(2). AB208–AB208. 7 indexed citations

Steinberg, Marcos W., et al.. (2018). Ozanimod (RPC1063), a selective S1PR1 and S1PR5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus. PLoS ONE. 13(4). e0193236–e0193236. 40 indexed citations

McLaren, David G., Stephen F. Previs, Robert D. Phair, et al.. (2016). Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux. Journal of Lipid Research. 57(3). 398–409. 9 indexed citations

Bossé, Yohan, Dirkje S. Postma, Don D. Sin, et al.. (2012). Molecular Signature of Smoking in Human Lung Tissues. Cancer Research. 72(15). 3753–3763. 93 indexed citations

Wang, Weixun, Nykia D. Walker, Li-Ji Zhu, et al.. (2012). Quantification of Circulating D-dimer by Peptide Immunoaffinity Enrichment and Tandem Mass Spectrometry. Analytical Chemistry. 84(15). 6891–6898. 18 indexed citations

Butler, Heather, Michael Schirm, Daniel Chelsky, et al.. (2007). An evaluation of multidimensional fingerprinting in the context of clinical proteomics. PROTEOMICS - CLINICAL APPLICATIONS. 1(5). 457–466. 2 indexed citations

Gao, Ji, Gregory J. Opiteck, Yves Dubaquié, et al.. (2005). Biomarker discovery in biological fluids. Methods. 35(3). 291–302. 49 indexed citations

10.

Gao, Ji, Stanley A. Hefta, Gregory J. Opiteck, et al.. (2004). Identification of in vitro protein biomarkers of idiosyncratic liver toxicity. Toxicology in Vitro. 18(4). 533–541. 37 indexed citations

11.

Gao, Ji, et al.. (2004). In Vitro Biomarker Discovery for Atherosclerosis by Proteomics. Molecular & Cellular Proteomics. 3(12). 1200–1210. 77 indexed citations

12.

Opiteck, Gregory J. & Julie E. Scheffler. (2004). Target class strategies in mass spectrometry-based proteomics. Expert Review of Proteomics. 1(1). 57–66. 8 indexed citations

13.

Hefta, Stanley A., et al.. (2003). A high-yield method to extract peptides from rat brain tissue. Analytical Biochemistry. 315(2). 183–188. 6 indexed citations

14.

Gao, Ji, Gregory J. Opiteck, Mark S. Friedrichs, Ashok Dongre, & Stanley A. Hefta. (2003). Changes in the Protein Expression of Yeast as a Function of Carbon Source. Journal of Proteome Research. 2(6). 643–649. 146 indexed citations

15.

Ginanni, Nicole, et al.. (2002). Biomarker Discovery in Urine by Proteomics. Journal of Proteome Research. 1(2). 161–169. 171 indexed citations

16.

Dongre, Ashok, Gregory J. Opiteck, W L Cosand, & Stanley A. Hefta. (2001). Proteomics in the post-genome age. Biopolymers. 60(3). 206–211. 23 indexed citations

17.

MacNair, John E., Gregory J. Opiteck, James W. Jorgenson, & M. Arthur Moseley. (1997). Rapid separation and characterization of protein and peptide mixtures using 1.5 μm diameter non-porous silica in packed capillary liquid chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry. 11(12). 1279–1285. 40 indexed citations

18.

Anderegg, Robert J., David S. Wagner, Kevin Blackburn, Gregory J. Opiteck, & James W. Jorgenson. (1997). A Multidimensional Approach to Protein Characterization. Journal of Protein Chemistry. 16(5). 523–526. 14 indexed citations

19.

Lewis, Kenneth C., Gregory J. Opiteck, James W. Jorgenson, & Douglas M. Sheeley. (1997). Comprehensive on-line RPLC-CZE-MS of peptides. Journal of the American Society for Mass Spectrometry. 8(5). 495–500. 88 indexed citations

20.

Rose, Donald J. & Gregory J. Opiteck. (1994). Two-Dimensional Gel Electrophoresis/Liquid Chromatography for the Micropreparative Isolation of Proteins. Analytical Chemistry. 66(15). 2529–2536. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact